Answers are grounded in this paper and cite their sources.
The development of varenicline reflects new understanding of how nicotine acts to increase craving for cigarettes. Two studies recently published in the Journal of the American Medical Association evaluated the effects of varenicline on quitting. These studies showed that, although varenicline improves quit rates relative to bupropion, it is not a magic bullet. Regardless, even a small increase in sustained quit rates will yield health benefits that far exceed any other clinical intervention.
No takes yet. Share an insight, caveat, or question.
Schroeder et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: